Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 30 September 2023
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
60
Renminbi (CNY)
17
Euro (EUR)
12
Indian rupee (INR)
5
Other currencies (CAD, DKK, GBP, HDK, SEK)
4
Swiss franc (CHF)
2
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
39
Public (from private) companies
24
Public companies
20
Funds
10
Cash and cash equivalents
5
Other assets
2
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
40
Products on the market
27
Preclinical
7
Phase I
8
Phase II
13
Phase III
5
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
24
Synthetic biology
17
Oncology
17
Digital Health
11
Central nervous system
11
Orphan diseases
8
Immunology/Inflammation
7
Medical technology / diagnostics
5
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a